Rockefeller Capital Management
EDIT icon

Rockefeller Capital Management’s Editas Medicine EDIT Stock Holding History

Rockefeller Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.9K Buy
23,040
+78
+0.3% +$165 ﹤0.01% 3203
2025
Q4 		$47.1K Buy
22,962
+425
+2% +$1.23K ﹤0.01% 3099
2025
Q3 		$78.2K Buy
+22,537
New +$62.9K ﹤0.01% 2699
2023
Q3 		– Sell
-18,533
Closed -$153K – 1573
2023
Q2 		$153K Buy
18,533
+379
+2% +$3.3K ﹤0.01% 1712
2023
Q1 		$131K Buy
18,154
+1,000
+6% +$8.89K ﹤0.01% 1872
2022
Q4 		$152K Sell
17,154
-1,765
-9% -$19.4K ﹤0.01% 1802
2022
Q3 		$231K Buy
18,919
+40
+0.2% +$623 ﹤0.01% 1586
2022
Q2 		$223K Buy
18,879
+2,243
+13% +$30.1K ﹤0.01% 1592
2022
Q1 		$316K Buy
16,636
+15,003
+919% +$279K ﹤0.01% 1501
2021
Q4 		$43K Sell
1,633
-6,260
-79% -$215K ﹤0.01% 2278
2021
Q3 		$323K Buy
7,893
+5,379
+214% +$295K ﹤0.01% 1413
2021
Q2 		$142K Buy
2,514
+465
+23% +$17.2K ﹤0.01% 1654
2021
Q1 		$86K Buy
2,049
+1,018
+99% +$58K ﹤0.01% 1672
2020
Q4 		$72K Buy
1,031
+467
+83% +$19.2K ﹤0.01% 1559
2020
Q3 		$15K Buy
+564
New +$18.4K ﹤0.01% 1880
2020
Q1 		– Sell
-7
Closed – – 2379
2019
Q4 		$0 Buy
+7
New +$175 ﹤0.01% 2083

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rockefeller Capital Management's EDIT Position: Q1 2026 in Review

Rockefeller Capital Management increased its Editas Medicine (EDIT) stake by 0.34% in Q1 2026, buying an estimated $165 and bringing the position to 23,040 shares worth $56.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3203.

Rockefeller Capital Management first reported a position in EDIT in Q4 2019 and has held it in 16 quarters since. The position peaked at $323K in Q3 2021. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Rockefeller Capital Management held 23,040 shares of Editas Medicine worth $56.9K as of Q1 2026.
  • Rockefeller Capital Management bought 78 Editas Medicine shares in Q1 2026, an estimated $165.
  • Editas Medicine made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3203 holding.
  • Rockefeller Capital Management first reported a position in Editas Medicine in Q4 2019 and has held it in 16 quarters since.
  • Rockefeller Capital Management's Editas Medicine position peaked at $323K in Q3 2021.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.